FindTrial
Sign In

Study on a Predictive Model for Immune Checkpoint Inhibitor Pneumonitis Based on Multi-Center and Multi-Omics Data

Study on a Predictive Model for Immune Checkpoint Inhibitor Pneumonitis Based on Multi-Center and Multi-Omics Data

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108859
Enrollment
Unknown
Registered
2025-09-08
Start date
2025-09-08
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

pneumonia-positive:None
pneumonia-negative:None

Sponsors

Southern Medical University Southern Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Hospitalized at Nanfang Hospital, Southern Medical University or Xiangyang Central Hospital between January 2016 and December 2023; 2.Pathologically confirmed lung cancer patients; 3.Treated with at least one cycle of PD-1/PD-L1 inhibitor monotherapy or combination therapy; 4.Availability of baseline chest CT images and tumor pathological H&E slides;

Exclusion criteria

Exclusion criteria: 1.Unavailable imaging data at the time of checkpoint inhibitor pneumonitis diagnosis; 2.Lack of clinical follow-up; 3.Patients with missing baseline chest CT images or tumor pathological H&E slides; 4.Other conditions deemed unsuitable for inclusion by investigators;

Design outcomes

Primary

MeasureTime frame
Area Under the Curve;—

Countries

China

Contacts

Public ContactDong ZHongyi

Southern Medical University Southern Hospital

630041126@qq.com+86 156 2621 7674

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026